Syngenta strengthens global leadership in agricultural biologicals
Acquires natural products and genetic strains assets from Novartis to boost biologicals research
Inaugurates cutting-edge production facility in South Carolina, USA
Biologicals portfolio to help farmers transition to more sustainable practices
Syngenta, a world leader in developing the next generation of biologicals products for agricultural use, is significantly expanding its biologicals research and development capabilities. Today, it announced that it has acquired the Novartis repository of natural compounds and genetic strains for agricultural use, while Novartis maintains exclusive rights to repository for pharmaceutical use. The transaction also includes transfer of the Novartis Natural Products and Biomolecular Chemistry team to Syngenta.
The move gives Syngenta access to an important source of novel leads for agricultural research, and offers Syngenta integrated capabilities in bioengineering, data science, fermentation, downstream processing, as well as analytics. As part of the agreement, which is expected to close on June 1st, Syngenta will also lease the Novartis fermentation pilot plant and science laboratories located in Basel, Switzerland. The acquisition builds upon a successful research collaboration between Syngenta and Novartis since 2019.
This acquisition follows the start-up of Syngenta’s new biologicals production facility in Orangeburg, South Carolina, US. The facility is Syngenta’s first world-scale production facility for agricultural biologicals in the US and will support growing demand for science-based and novel biological solutions in both the North and Latin American markets.
These developments come as Syngenta forges multiple collaborations to accelerate the pace of biologicals innovation, as well as fortify its position in key growth areas such as nutrient use efficiency. Over the past months Syngenta has announced various collaborations, including with:
- Provivi for new pheromone solutions, targeting devastating pests in key crops across Asia
- Ginkgo Bioworks to accelerate the launch of innovative biologicals
- Intrinsyx Bio in the fast growth area of nutrient use efficiency
- Lavie Bio to discover and develop novel bio-insecticide
- Lithos Crop Protect for sprayable pheromone targeting the Western Corn Rootworm pest
- TraitSeq to leverage AI to accelerate the development of innovative biologicals.
Camilla Corsi, Syngenta’s Global Head of Crop Protection Research and Development, said: “We invest significantly to offer the industry’s most advanced pipeline of innovative agricultural solutions. The integration of these world-class assets opens a new chapter on our ability to develop cutting-edge biological solutions for farmers and reflects our commitment to drive solutions that continue to elevate the sustainability of agriculture.”
Jonathan Brown, Global Head of Syngenta’s Seedcare and Biologicals business, said: “With the broadest and most comprehensive portfolio across all segments of biological products, we have established ourselves as a leader in the industry. In a constantly growing market, it is important to ensure a pipeline capable of supporting continuous evolutions. I am convinced that this acquisition will allow us to maintain our capacity to innovate.”
Biologicals are agricultural technologies that harness nature to protect and improve the health of crops. Biocontrols, biostimulants and nutrient use efficiency products complement conventional agricultural inputs, offering farmers greater flexibility to manage pests and diseases, address abiotic stress, and enhance nutrient use efficiency and soil health. Biologicals are crucial for supporting regenerative agriculture and helping agriculture shift towards more sustainable farming practices, and contribute toward Syngenta’s fulfilment of commitments outlined in its Sustainability Priorities. Syngenta has been systematically expanding its focus on biologicals since its acquisition of Italy’s Valagro in 2020.
Media Contacts
Syngenta Media Relations
media@syngentagroup.com
Web Resources
About Syngenta
Syngenta is a global leader in agricultural innovation with a presence in more than 100 countries. Syngenta is focused on developing technologies and farming practices that empower farmers, so they can make the transformation required to feed the world’s population while preserving our planet. Its bold scientific discoveries deliver better benefits for farmers and society on a bigger scale than ever before. Guided by its Sustainability Priorities, Syngenta is developing new technologies and solutions that support farmers to grow healthier plants in healthier soil with a higher yield. Syngenta Crop Protection is headquartered in Basel, Switzerland; Syngenta Seeds is headquartered in the United States. Read our stories and follow us on LinkedIn, Instagram & X.
Cautionary Statement Regarding Forward-Looking Statements
This document may contain forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Syngenta, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or commodity prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.
